Retail investors account for 49% of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.’s (SHSE:600196) ownership, while private companies account for 36%
Key Insights Every investor in Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SHSE:600196) should be aware of the most powerful shareholder groups. We can...
Hong Kong stocks slip, index ends week in red on jitters before China’s key economic data
Investors are gearing up for a data-packed Monday, when China’s statistics bureau is due to announce industrial production, retail sales and fixed-asset investment numbers....
Asian stocks slide, yen wobbles ahead of BOJ verdict
Asian stocks fell on Friday as investors pondered the outlook for U.S. rates after the Federal Reserve tempered its rate-cut views even as inflation...
China to dominate final day of G7, Pope to lead AI discussions
Group of Seven (G7) leaders hold a final day of talks at their annual summit on Friday, with China topping the agenda before Pope...
Would Shanghai Bright Power Semiconductor (SHSE:688368) Be Better Off With Less Debt?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment...
